Alimta®

Alimta® is the very first mesothelioma chemotherapy drug to be approved by the Food and Drug Administration (FDA) to treat patients suffering from malignant pleural mesothelioma cancer. Also known as Pemetrexed, Alimta® is administered to mesothelioma patients who are unable to undergo mesothelioma surgery to remove cancerous tissue.

Developed in 2000, Alimta® has been hailed as a "huge breakthrough" in treating mesothelioma cancer patients. In clinical trials at Britain's Newcastle Freeman Hospital, Alimta® was administered to 27 British mesothelioma sufferers, most of whom were former construction workers. The use of Alimta® resulted in a rapid improvement of their symptoms. Trial leader Professor Hilary Calvert stated that half of the patients experienced a decrease in tumor size and that most of the patients had marked improvement in their symptoms. Professor Calvert called the trial's findings "the best results I've seen in my career."

Alimta® is most generally administered along with Cisplatin, a chemotherapy drug. Together, these two drugs have been known to extend the life of asbestos cancer patients by several months, and are beneficial in controlling mesothelioma symptoms, such as discomfort and breathing difficulties.

Alimta® treatment occurs over a 21-day period. On the first day of treatment, Alimta® is administered intravenously, which takes about fifteen minutes. Cisplatin is infused following the first dose of Alimta® but is not administered again until the 22nd day of treatment. Side effects associated with Alimta® include fatigue, anemia, fever, upset stomach, and mouth sores, but certain antibiotics can control these unpleasant effects of the chemotherapy treatment.

As with any mesothelioma treatment method, your doctor must determine whether or not you are a good candidate for Alimta® treatment.

Source

Alimta
http://www.alimta.com/pat/index.jsp

If you have any questions regarding treatment options or your legal rights, please contact us.

Free Mesothelioma Information Packet

Enter your information to receive a comprehensive mesothelioma packet free of charge at your doorstep within 24 hours.

Yes   No

Mesothelioma Mesothelioma Treatment
Conventional Therapies Mesothelioma Surgery Mesothelioma Radiation Mesothelioma Chemotherapy Alimta Cisplatin Carboplatin Gemcitabine Onconase Navelbine Physical Therapy Alternative Treatments Experimental Therapies Treatment by Stage Mesothelioma Doctors Mesothelioma Experts Clinical Trials Mesothelioma Clinics Ask Your Doctor Caregivers and the Aging Mesothelioma Research Mesothelioma Resources Counseling Resources Mesothelioma Treatment Alerts
Asbestos Cancer Asbestos Exposure Mesothelioma News Veterans & Mesothelioma Mesothelioma Attorney FREE Case Evaluation Top Mesothelioma Doctors

Raja M. Flores, M.D.
Dr. Raja M. Flores is an Associate Professor of Cardiothoracic Surgery at Memorial Sloan-Kettering Medical Center in New York and is considered a leading expert in the study and treatment of malignant pleural mesothelioma.

Lary Robinson, M.D.
Dr. Lary A. Robinson is the Director of Cardiovascular and Thoracic Surgery at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida where he evaluates and treats mesothelioma.

David Rice, M.D.
Dr. David Rice is an Associate Professor and Assistant Surgeon at The University of Texas M.D. Anderson Cancer Center where he serves as the director of the Minimally Invasive Surgery and Mesothelioma programs.

This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
verify here.